STUDY OF INFECTIOUS COMPLICATIONS IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMAB

被引：0
|
作者：
Diaz, Galvez Francisco J. [1 ]
Barrigon Fernando, Escalante [2 ]
Vals Julio, Davila [3 ]
Saavedra Veronica, Campuzano [1 ]
Gomez Jorge, Labrador [1 ]
Garcia Abelardo, Barez [3 ]
Maria Del Carmen, Hermoso Martinez [3 ]
Nuno Rodolfo, Alvarez [1 ]
机构：
[1] Hosp Univ Burgos, Burgos, Spain
[2] Complejo Asistencial Univ Leon, Leon, Spain
[3] Complejo Asistencial Avila, Avila, Spain
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-015
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [1] Infectious Complications of Daratumumab-Containing Therapy for Multiple Myeloma
    Johnsrud, Andrew
    Susanibar, Sandra
    Kamimoto, Jorge Jo
    Johnsrud, Joyce
    Kothari, Atul
    Burgess, Mary
    Schinke, Carolina D.
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Davies, Faith E.
    Morgan, Gareth J.
    Van Rhee, Frits
    Crescencio, Juan Carlos Rico
    BLOOD, 2017, 130
  • [2] Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
    Nahi, Hareth
    Chrobok, Michael
    Gran, Charlotte
    Lund, Johan
    Gruber, Astrid
    Gahrton, Gosta
    Ljungman, Per
    Wagner, Arnika Kathleen
    Alici, Evren
    PLOS ONE, 2019, 14 (02):
  • [3] Use of Daratumumab in Patients With Previously Treated Multiple Myeloma
    Patel, Ashwin P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14)
  • [4] Infectious Complications in Patients Treated with Idecabtagene Vicleucel for Relapsed and Refractory Multiple Myeloma
    Little, Jessica S.
    Shah, Parth
    Sperling, Adam S.
    Branagan, Andrew R.
    Nadeem, Omar
    Yee, Andrew J.
    Raje, Noopur S.
    Munshi, Nikhil C.
    Hammond, Sarah
    BLOOD, 2021, 138 : 3839 - +
  • [5] Infectious and immunological sequelae of daratumumab in multiple myeloma
    Johnsrud, Andrew J.
    Johnsrud, Joyce J.
    Susanibar, Sandra A.
    Kamimoto, Jorge J.
    Kothari, Atul
    Burgess, Mary
    Van Rhee, Frits
    Rico, Juan C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) : 187 - 189
  • [6] Risk of RBC alloimmunization in multiple myeloma patients treated by Daratumumab
    Ye, Zhan
    Wolf, Laurie A.
    Mettman, Daniel
    Plapp, Fred, V
    VOX SANGUINIS, 2020, 115 (02) : 207 - 212
  • [7] Risk of RBC Alloimmunization in Multiple Myeloma Patients Treated by Daratumumab
    Ye, Zhan
    Wolf, Laurie
    Plapp, Fred
    TRANSFUSION, 2018, 58 : 188A - 188A
  • [8] INFECTIOUS COMPLICATIONS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE. EXPERIENCE AT MANISES HOSPITAL
    Garcia, A.
    Carretero, V
    Pacios, A.
    Canovas, V
    Picon, I
    HAEMATOLOGICA, 2018, 103 : 308 - 308
  • [9] Outcomes of COVID-19 in multiple myeloma patients treated with daratumumab
    Jin, Dian
    He, Jingsong
    Wu, Wenjun
    Han, Xiaoyan
    Le, Jing
    Shu, Wenxiu
    Fu, Jiaping
    Kong, Hongwei
    Wang, Gang
    Zhou, Xiujie
    Qu, Zhigang
    Cai, Zhen
    He, Donghua
    CANCER SCIENCE, 2024, 115 (01) : 237 - 246
  • [10] Clinical Factors Associated to VTE in Multiple Myeloma Patients Treated with Daratumumab
    Subramanian, Naveen G.
    Aung, Fleur M.
    Patel, Krina
    Lee, Hans C.
    Jin, Shida
    Young, Elliana
    Hernandez, Cristhiam Mauricio Rojas
    BLOOD, 2022, 140 : 5177 - 5179
12345